Akero Therapeutics Inc (NASDAQ:AKRO)

43.70
Delayed Data
As of Dec 08
 +1.51 / +3.58%
Today’s Change
7.52
Today|||52-Week Range
48.24
+106.62%
Year-to-Date
No recent news for Akero Therapeutics Inc.

Today’s Trading

Previous close42.19
Today’s open41.50
Day’s range40.63 - 44.67
Volume35,089
Average volume (3 months)1,196,636
Market cap$2.1B
Data as of 3:21pm ET, 12/08/2022

Growth & Valuation

Earnings growth (last year)-14.94%
Earnings growth (this year)-10.79%
Earnings growth (next 5 years)-14.08%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book9.39

Competitors

 Today’s
change
Today’s
% change
SUPNSupernus Pharmaceuti...+0.11+0.31%
----
KRYSKrystal Biotech Inc-1.85-2.42%
GRFSGrifols SA-0.16-2.02%
Data as of 3:21pm ET, 12/08/2022

Financials

Next reporting dateMarch 20, 2023
EPS forecast (this quarter)-$0.77
Annual revenue (last year)$0.00
Annual profit (last year)-$100.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
South San Francisco, California

Forecasts